(Q35802758)

10 August 2017

1 reference

title

Immunobiology of the Tomatine adjuvant (English)

1 reference

10 August 2017

Morrow WJ

1

1 reference

10 August 2017

Yang YW

series ordinal

2

1 reference

10 August 2017

Sheikh NA

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

22

1 reference

10 August 2017

issue

19

1 reference

10 August 2017

page(s)

2380-2384

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.022

10 August 2017

1 reference

Can soluble antigens induce CD8+ cytotoxic T-cell responses? A paradox revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.022

Dual specificity of sterol-mediated glycoalkaloid induced membrane disruption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.022

Molecular basis of glycoalkaloid induced membrane disruption.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.022

Glycoalkaloids selectively permeabilize cholesterol containing biomembranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.022

The Influence of Aluminium Hydroxide Content, Dose Volume and the Inclusion of Saponin on the Efficacy of Inactivated Foot-and-Mouth Disease Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.022

High alpha-tomatine content in ripe fruit of Andean Lycopersicon esculentum var. cerasiforme: developmental and genetic aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.022

The ultrastructure of tomatine adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.022

Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.022

Generation of antigen specific CD8+ cytotoxic T cells following immunization with soluble protein formulated with novel glycoside adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.022

Differential requirements for CTL generation by novel immunostimulants: APC tropism, use of the TAP-independent processing pathway, and dependency on CD80/CD86 costimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.022

Novel aggregate structure adjuvants modulate lymphocyte proliferation and Th1 and Th2 cytokine profiles in ovalbumin immunized mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.022

Potentiation by a novel alkaloid glycoside adjuvant of a protective cytotoxic T cell immune response specific for a preerythrocytic malaria vaccine candidate antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.022

Tomatine as an adjuvant in malaria vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.022

Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.022

The apoptotic and necrotic effects of tomatine adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.022

Guns, genes, and spleen: a coming of age for rational vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.022

10.1016/J.VACCINE.2004.03.022

7 January 2021

Identifiers

DOI

1 reference

10 August 2017

1 reference